Debrisan (Dextranomer) was subjected to a simple open assessment in the treatment of fifty-three chronic leg ulcers and thirty pressure sores in eight hospitals. It was found that 70% of leg ulcers and 76% of pressure sores improved, with a noticeable cleansing effect being evident in 79% and 83% respectively. No side-effects were recorded.
Get full access to this article
View all access options for this article.
References
1.
ÅbergMHednerUJacobssonSRothmanU (1976) Fibrinolytic activity in wound secretions. Scandinavian Journal of Plastic and Reconstructive Surgery10, 103.
2.
BarbenalJ CJordenM MNicolS MClarkeM O (1977) Incidence of pressure sores in the Greater Glasgow Health Board Area Editorial (1975) The treatment of varicose veins. Lancetii, 311.
3.
FlodenC-HWikstromK (1978) Controlled clinical trial with Dextranomer (Debrisan) on venous leg ulcers. Current Therapeutic Research24, 753.
4.
HMSO (1974) Morbidity statistics from general practice: Second national study 1970–71.
5.
JacobssonSRothmanUArtursonGGanrotKHaegerKJuhlinI (1976) A new principle for the cleansing of infected wounds. Scandinavian Journal of Plastic and Reconstructive Surgery10, 65.
6.
McClemontE J WShandIRamsayB (1979) Pressure sores: A new method of treatment. British Journal of Clinical Practice33, 21.
7.
MillardL GRobertsM MGatecliffeM (1977) Chronic leg ulcers treated by the pinch graft method. British Journal of Dermatology97, 289.
8.
MummeryR VRichardsonW W (1979) Clinical trial of Debrisan in superficial ulceration. Journal of International Medical Research7, 4, 263.
9.
New Scientist (1977) Fluid beds make for healthy patients. 24th February, p 459.
10.
PetersonN CBittmanS (1971) The epidemiology of pressure sores. Scandinavian Journal of Plastic and Reconstructive Surgery5, 62.
